Society guideline links: Spondyloarthritis

Introduction — 

This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Psoriatic arthritis in adults" and "Society guideline links: Juvenile idiopathic arthritis" and "Society guideline links: Undifferentiated early inflammatory arthritis".)

International

●Assessment of SpondyloArthritis International Society (ASAS)-European League Against Rheumatism (EULAR): Recommendations for the management of axial spondyloarthritis, update (2022)

●ASAS: Development of quality standards to improve the quality of health and care services for patients with axial spondyloarthritis (2019)

●An international task force recommendation for treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target, 2017 update (published 2018)

●ASAS: Development of an endorsed recommendation for the early referral of patients with a suspicion of axial spondyloarthritis (2015)

Canada

●Canadian Rheumatology Association (CRA)/Spondyloarthritis Research Consortium of Canada (SPARCC): Treatment recommendations for the management of axial spondyloarthritis (2024)

●Choosing Wisely Canada: Don't order an HLA-B27 unless spondyloarthritis is suspected based on specific signs or symptoms (2024)

United States

●American College of Radiology (ACR): ACR Appropriateness Criteria on inflammatory back pain – Known or suspected axial spondyloarthritis (2021)

●American College of Rheumatology (ACR)/Spondylitis Association of America (SAA)/Spondyloarthritis Research and Treatment Network (SPARTAN): Recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis, update (2019)

Europe

●Assessment of SpondyloArthritis International Society (ASAS)-European League Against Rheumatism (EULAR): Recommendations for the management of axial spondyloarthritis, update (2022)

●EULAR: Recommendations for physical activity in people with inflammatory arthritis and osteoarthritis (2018)

●EULAR: Recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice (2015)

United Kingdom

●British Society for Rheumatology (BSR): Guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs (2025)

●British Society of Spondyloarthritis (BRITSpA): Recommendations for acquisition and interpretation of MRI of the spine and sacroiliac joints in the diagnosis of axial spondyloarthritis in the UK (2019)

●National Institute for Health and Care Excellence (NICE): Quality standard on spondyloarthritis (2018)

●NICE: Guideline on spondyloarthritis in over 16s – Diagnosis and management (2017)

India

●Asia Pacific League of Associations for Rheumatology (APLAR): Axial spondyloarthritis treatment recommendations, 2018 (published 2019)

Australia–New Zealand

●Asia Pacific League of Associations for Rheumatology (APLAR): Axial spondyloarthritis treatment recommendations, 2018 (published 2019)

●Consensus statements on the imaging of axial spondyloarthritis in Australia and New Zealand (2017)

Japan

●Asia Pacific League of Associations for Rheumatology (APLAR): Axial spondyloarthritis treatment recommendations, 2018 (published 2019)